UBS maintains support for A2 Milk Company Ltd (ASX:A2M)

Formula prices are falling in China, but UBS analysts are optimistic about the outlook for A2 Milk Company Ltd (ASX: A2M), according to The Australian.

According to the report UBS has a neutral rating on the company, with a recent visit to China “reaffirming” its robust medium term outlook for A2 Milk.

Goldman Sachs is also fond of the company, expecting it to net good earnings results through to FY20, but investors are no doubt spooked by A2’s share price drop of 24% from its late March 52-week high of $13.17 to sit at $9.95 at the time of writing.

Baby formula star stock Bellamy’s Australia Ltd (ASX: BAL) will likely register the impact of price cuts in China, with its share price already slipping 46% from its own late March 52-week high of $22.52 to sit at $12.17 at the time of writing.

Bubs Australia Ltd (ASX: BUB) and Wattle Health Australia Ltd (ASX: WHA) are smaller players in the sector with Bubs managing to maintain its share price over the past 6 months while Wattle’s shares have slipped.

Japanese Billionaire’s Prediction Will Give You Goosebumps

When a veritable investing and entrepreneurial genius speaks, it pays to listen.

In fact, he's now preparing a $100B "war chest" to invest entirely in this "terrifying" new technology, which could spell huge profits for investors.

Click here to learn about this technology and how you can profit!

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of A2 Milk. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.